Charles Schwab’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-109,717
| Closed | -$2.03M | – | 3593 |
|
|
2023
Q3 | $2.03M | Sell |
109,717
-49,161
| -31% | -$911K | ﹤0.01% | 2593 |
|
|
2023
Q2 | $1.76M | Sell |
158,878
-175,291
| -52% | -$1.94M | ﹤0.01% | 2587 |
|
|
2023
Q1 | $4.49M | Buy |
334,169
+56,461
| +20% | +$758K | ﹤0.01% | 2253 |
|
|
2022
Q4 | $3.44M | Buy |
277,708
+115,573
| +71% | +$1.43M | ﹤0.01% | 2389 |
|
|
2022
Q3 | $2.26M | Buy |
162,135
+215
| +0.1% | +$3K | ﹤0.01% | 2549 |
|
|
2022
Q2 | $2.24M | Sell |
161,920
-15,940
| -9% | -$220K | ﹤0.01% | 2538 |
|
|
2022
Q1 | $2.89M | Buy |
177,860
+112,541
| +172% | +$1.83M | ﹤0.01% | 2518 |
|
|
2021
Q4 | $1.07M | Sell |
65,319
-4,892
| -7% | -$79.8K | ﹤0.01% | 2884 |
|
|
2021
Q3 | $1.04M | Sell |
70,211
-116,382
| -62% | -$1.73M | ﹤0.01% | 2860 |
|
|
2021
Q2 | $3.73M | Buy |
186,593
+9,553
| +5% | +$191K | ﹤0.01% | 2487 |
|
|
2021
Q1 | $4.09M | Sell |
177,040
-25,661
| -13% | -$592K | ﹤0.01% | 2387 |
|
|
2020
Q4 | $5.01M | Buy |
202,701
+1,631
| +0.8% | +$40.3K | ﹤0.01% | 2217 |
|
|
2020
Q3 | $8.34M | Sell |
201,070
-2,833
| -1% | -$117K | ﹤0.01% | 1805 |
|
|
2020
Q2 | $9.77M | Buy |
203,903
+36,086
| +22% | +$1.73M | ﹤0.01% | 1667 |
|
|
2020
Q1 | $10.6M | Buy |
167,817
+4,006
| +2% | +$252K | 0.01% | 1414 |
|
|
2019
Q4 | $20.3M | Buy |
163,811
+3,125
| +2% | +$387K | 0.01% | 1202 |
|
|
2019
Q3 | $10.7M | Buy |
160,686
+10,301
| +7% | +$684K | 0.01% | 1571 |
|
|
2019
Q2 | $12M | Buy |
150,385
+17,609
| +13% | +$1.4M | 0.01% | 1479 |
|
|
2019
Q1 | $14.9M | Buy |
132,776
+12,317
| +10% | +$1.38M | 0.01% | 1312 |
|
|
2018
Q4 | $12.1M | Sell |
120,459
-361
| -0.3% | -$36.4K | 0.01% | 1326 |
|
|
2018
Q3 | $15.3M | Buy |
120,820
+10,015
| +9% | +$1.27M | 0.01% | 1347 |
|
|
2018
Q2 | $9.3M | Buy |
110,805
+56,556
| +104% | +$4.75M | 0.01% | 1649 |
|
|
2018
Q1 | $3.34M | Buy |
54,249
+8,471
| +19% | +$521K | ﹤0.01% | 2129 |
|
|
2017
Q4 | $2.68M | Sell |
45,778
-2,751
| -6% | -$161K | ﹤0.01% | 2201 |
|
|
2017
Q3 | $2.82M | Sell |
48,529
-13,643
| -22% | -$792K | ﹤0.01% | 2144 |
|
|
2017
Q2 | $7.53M | Sell |
62,172
-2,131
| -3% | -$258K | 0.01% | 1543 |
|
|
2017
Q1 | $7.27M | Buy |
64,303
+5,355
| +9% | +$606K | 0.01% | 1535 |
|
|
2016
Q4 | $6.41M | Sell |
58,948
-1,384
| -2% | -$150K | 0.01% | 1570 |
|
|
2016
Q3 | $9.93M | Buy |
60,332
+3,903
| +7% | +$642K | 0.01% | 1166 |
|
|
2016
Q2 | $8.05M | Buy |
56,429
+9,112
| +19% | +$1.3M | 0.01% | 1222 |
|
|
2016
Q1 | $6.08M | Sell |
47,317
-4,741
| -9% | -$609K | 0.01% | 1393 |
|
|
2015
Q4 | $7.78M | Buy |
52,058
+4,776
| +10% | +$713K | 0.01% | 1194 |
|
|
2015
Q3 | $7.84M | Buy |
47,282
+13,000
| +38% | +$2.16M | 0.01% | 1146 |
|
|
2015
Q2 | $8.28M | Buy |
34,282
+5,411
| +19% | +$1.31M | 0.01% | 1186 |
|
|
2015
Q1 | $8.14M | Buy |
28,871
+3,909
| +16% | +$1.1M | 0.01% | 1149 |
|
|
2014
Q4 | $3.9M | Buy |
24,962
+1,910
| +8% | +$298K | 0.01% | 1618 |
|
|
2014
Q3 | $5.46M | Buy |
23,052
+6,173
| +37% | +$1.46M | 0.01% | 1291 |
|
|
2014
Q2 | $4M | Sell |
16,879
-9,620
| -36% | -$2.28M | 0.01% | 1570 |
|
|
2014
Q1 | $8.74M | Buy |
26,499
+4,689
| +21% | +$1.55M | 0.02% | 900 |
|
|
2013
Q4 | $1.49M | Buy |
21,810
+2,546
| +13% | +$174K | ﹤0.01% | 2070 |
|
|
2013
Q3 | $1.48M | Buy |
19,264
+1,713
| +10% | +$132K | ﹤0.01% | 2012 |
|
|
2013
Q2 | $771K | Buy |
+17,551
| New | +$771K | ﹤0.01% | 2304 |
|